Research news and discoveries from Mass General Brigham
Bench PressBench PressBench PressBench Press
  • Home
  • About Us
  • Science Insights
NextPrevious

Combining Multiple Types of Brain Scans Reveals New Patterns of Alzheimer’s Disease

May 28, 2026
1

Lisa Nickerson, PhD

David Harper, PhD

You (Lily) Cheng, PhD

Alzheimer’s disease (AD) symptoms and progression vary widely across people. Although AD is defined by the presence of amyloid-beta plaques and tau tangles, these “hallmarks” may accumulate at different rates and in different regions across the brain. While individual brain scans using technologies like magnetic resonance imaging (MRI) or positron emission tomography (PET) can capture snapshots of disease signals, they only offer clinicians a partial picture when considered individually.

In a new study led by You (Lily) Cheng, PhD, David Harper, PhD, and Lisa Nickerson, PhD, of McLean Hospital, researchers tested whether combining multiple types of brain scans from the same person could better capture the complexity of Alzheimer’s disease.

Using a new machine learning model for fusing different kinds of images, they analyzed amyloid and tau PET scans together with multiple MRI measures of brain structure from 274 participants in the Alzheimer’s Disease Neuroimaging Initiative.

Through this data-fusion approach, the team was able to identify integrated, spatially detailed brain patterns linked to cognitive decline, clinical diagnosis and genetic risk. One pattern connecting tau buildup with structural brain changes was especially accurate at distinguishing mild cognitive impairment from mild dementia, a distinction that can be difficult to make in clinical practice. Another pattern, driven primarily by amyloid burden, differentiated carriers of APOE ε4 (a major genetic risk factor for AD) from non‑carriers.

According to the authors, this tactic of combining multiple brain measures into a unified framework could help improve disease staging and guide more targeted approaches in research and care.

Published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring on May 21, 2026 | Read the paper: “Investigating the Amyloid-Tau-Neurodegeneration Framework in Alzheimer’s Disease Using Semi-Supervised Multimodal Imaging Data Fusion”

Summary reviewed by: You (Lily) Cheng, PhD, lead author; David Harper, PhD, and Lisa Nickerson, PhD, senior authors

Tags:
Brain and Nervous System Conditions, Brain Imaging

Katie Grant

More posts by Katie Grant

Related Projects:

Clinician Perspectives Reveal Challenges and Opportunities in Dementia-Related Surgical Care

brain and nervous system conditions geriatrics surgery

View more

Clinician Perspectives Reveal Challenges and Opportunities in Dementia-Related Surgical Care

brain and nervous system conditions geriatrics surgery

Clinician Perspectives Reveal Challenges and Opportunities in Dementia-Related Surgical Care
2026-08-19

New Strategy Aims to Restore Healthy Tau Balance in 4R Tauopathies

brain and nervous system conditions

View more

New Strategy Aims to Restore Healthy Tau Balance in 4R Tauopathies

brain and nervous system conditions

New Strategy Aims to Restore Healthy Tau Balance in 4R Tauopathies
2026-08-19

Strategies to Strengthen Data Privacy for Brain-Computer Interface Users

brain and nervous system conditions technology

View more

Strategies to Strengthen Data Privacy for Brain-Computer Interface Users

brain and nervous system conditions technology

Strategies to Strengthen Data Privacy for Brain-Computer Interface Users
2026-08-17

Study Identifies Brain Cells that May Boost Ongoing Inflammation in Multiple Sclerosis

brain and nervous system conditions immunology

View more

Study Identifies Brain Cells that May Boost Ongoing Inflammation in Multiple Sclerosis

brain and nervous system conditions immunology

Study Identifies Brain Cells that May Boost Ongoing Inflammation in Multiple Sclerosis
2026-08-17

Study Highlights Why Some Patients with Treatment-Resistant Breast Cancer May Benefit from Drugs that Target CDK2

cancer

View more

Study Highlights Why Some Patients with Treatment-Resistant Breast Cancer May Benefit from Drugs that Target CDK2

cancer

Study Highlights Why Some Patients with Treatment-Resistant Breast Cancer May Benefit from Drugs that Target CDK2
2026-08-12

Pre-Treatment With Vorasidenib May Improve, Not Impair, Response to Later Chemoradiation in IDH-Mutant Glioma

brain and nervous system conditions cancer

View more

Pre-Treatment With Vorasidenib May Improve, Not Impair, Response to Later Chemoradiation in IDH-Mutant Glioma

brain and nervous system conditions cancer

Pre-Treatment With Vorasidenib May Improve, Not Impair, Response to Later Chemoradiation in IDH-Mutant Glioma
2026-08-12

Using AI to Simplify Neuroradiology Reports Without Losing Accuracy

artificial intelligence brain imaging radiology

View more

Using AI to Simplify Neuroradiology Reports Without Losing Accuracy

artificial intelligence brain imaging radiology

Using AI to Simplify Neuroradiology Reports Without Losing Accuracy
2026-08-10

Multicenter Study Suggests Early Rasburicase Prevents Kidney Failure and Death in Tumor Lysis Syndrome

nephrology

View more

Multicenter Study Suggests Early Rasburicase Prevents Kidney Failure and Death in Tumor Lysis Syndrome

nephrology

Multicenter Study Suggests Early Rasburicase Prevents Kidney Failure and Death in Tumor Lysis Syndrome
2026-08-10

Leave a Comment

Cancel reply

Your email address will not be published. Required fields are marked *

  • Home
  • Research
    • Brain Research
    • Cancer
    • Heart
  • History
    • Nursing History Stories
  • Science Insights from Mass General Brigham
Bench Press